PSS World Medical (PSSI) Announces Plans to Offer $250 Milion in Senior Notes Due 2022
Up)
PSS World Medical, Inc. (Nasdaq: PSSI) announced today its intention to offer, subject to market and other conditions, approximately $250 million aggregate principal amount of senior notes due 2022. The Company intends to use a portion of the net proceeds from the offering to repay borrowings under its new credit facility and to partially pre-fund the repayment of its 3.125% convertible notes due 2014 and for general corporate purposes, including potential repurchases of common stock and acquisitions.
The notes are being offered inside the United States to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
The notes are being offered inside the United States to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: UBS Starts PSS World Medical (PSSI) at Buy; Get Past Tough Flu Comps; Shares Look Undervalued
- Auxilium (AUXL) Files Suit Against Watson (WPI) Over Testim 1% Gel
- Baxter Int'l (BAX) says low-glucose PD regimen has favorable impact on ESRD patients w/ diabetes
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
